Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Prakhar Agrawal is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $278.90 | — | — | Initiates | → Neutral | Get Alert |
| 06/20/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.07 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | AKRO | Buy Now | Akero Therapeutics | $23.46 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | AKRO | Buy Now | Akero Therapeutics | $23.46 | — | — | Reiterates | → Overweight | Get Alert |
| 06/03/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 05/28/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.07 | — | — | Reiterates | → Overweight | Get Alert |
| 05/03/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 04/09/2024 | GPCR | Buy Now | Structure Therapeutics | $39.85 | 63.11% | → $65 | Initiates | → Overweight | Get Alert |
| 02/23/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $7.07 | — | — | Initiates | → Overweight | Get Alert |
| 02/20/2024 | RAPT | Buy Now | RAPT Therapeutics | $3.08 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/08/2023 | MLTX | Buy Now | MoonLake | $43.97 | 77.39% | → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 10/11/2023 | AKRO | Buy Now | Akero Therapeutics | $23.46 | 66.24% | $69 → $39 | Maintains | Overweight | Get Alert |
| 10/04/2023 | AKRO | Buy Now | Akero Therapeutics | $23.46 | 194.12% | → $69 | Reiterates | Overweight → Overweight | Get Alert |
| 09/19/2023 | AKRO | Buy Now | Akero Therapeutics | $23.46 | 194.12% | → $69 | Initiates | → Overweight | Get Alert |
| 09/18/2023 | MLTX | Buy Now | MoonLake | $43.97 | 47.83% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 09/14/2023 | MLTX | Buy Now | MoonLake | $43.97 | 47.83% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | MLTX | Buy Now | MoonLake | $43.97 | 47.83% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $13 → $15 | Maintains | Buy | Get Alert |
| 07/03/2023 | MLTX | Buy Now | MoonLake | $43.97 | 47.83% | $29 → $65 | Maintains | Overweight | Get Alert |
| 06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | $58 → $48 | Downgrade | Overweight → Neutral | Get Alert |
| 04/17/2023 | TGTX | Buy Now | TG Therapeutics | $17.70 | 35.59% | → $24 | Reiterates | → Overweight | Get Alert |
| 03/20/2023 | MLTX | Buy Now | MoonLake | $43.97 | -34.05% | $23 → $29 | Maintains | Overweight | Get Alert |
| 03/06/2023 | MLTX | Buy Now | MoonLake | $43.97 | -47.69% | → $23 | Reiterates | → Overweight | Get Alert |
| 02/14/2023 | MLTX | Buy Now | MoonLake | $43.97 | -47.69% | → $23 | Initiates | → Overweight | Get Alert |
| 02/07/2023 | TGTX | Buy Now | TG Therapeutics | $17.70 | 35.59% | $18 → $24 | Maintains | Overweight | Get Alert |
| 02/03/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | $3 → $0.75 | Maintains | Neutral | Get Alert |
| 09/14/2022 | DICE | Buy Now | DICE Therapeutics | — | — | → $36 | Initiates | → Overweight | Get Alert |
| 07/15/2022 | TCRT | Buy Now | Alaunos Therapeutics | $0.70 | 328.57% | → $45 | Assumes | → Overweight | Get Alert |
| 06/13/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | → $21 | Assumes | → Overweight | Get Alert |
| 05/24/2022 | RAPT | Buy Now | RAPT Therapeutics | $3.08 | 1328.57% | → $44 | Assumes | → Overweight | Get Alert |
